122 related articles for article (PubMed ID: 36573331)
21. NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL.
Del Giudice I; Rossi D; Chiaretti S; Marinelli M; Tavolaro S; Gabrielli S; Laurenti L; Marasca R; Rasi S; Fangazio M; Guarini A; Gaidano G; Foà R
Haematologica; 2012 Mar; 97(3):437-41. PubMed ID: 22207691
[TBL] [Abstract][Full Text] [Related]
22. NOTCH1 mutations in CLL associated with trisomy 12.
Balatti V; Bottoni A; Palamarchuk A; Alder H; Rassenti LZ; Kipps TJ; Pekarsky Y; Croce CM
Blood; 2012 Jan; 119(2):329-31. PubMed ID: 22086416
[TBL] [Abstract][Full Text] [Related]
23. The γ-secretase inhibitor PF-03084014 combined with fludarabine antagonizes migration, invasion and angiogenesis in NOTCH1-mutated CLL cells.
López-Guerra M; Xargay-Torrent S; Rosich L; Montraveta A; Roldán J; Matas-Céspedes A; Villamor N; Aymerich M; López-Otín C; Pérez-Galán P; Roué G; Campo E; Colomer D
Leukemia; 2015 Jan; 29(1):96-106. PubMed ID: 24781018
[TBL] [Abstract][Full Text] [Related]
24. Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase.
Obermann EC; Went P; Tzankov A; Pileri SA; Hofstaedter F; Marienhagen J; Stoehr R; Dirnhofer S
J Clin Pathol; 2007 Jul; 60(7):794-7. PubMed ID: 16950856
[TBL] [Abstract][Full Text] [Related]
25. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.
Stilgenbauer S; Schnaiter A; Paschka P; Zenz T; Rossi M; Döhner K; Bühler A; Böttcher S; Ritgen M; Kneba M; Winkler D; Tausch E; Hoth P; Edelmann J; Mertens D; Bullinger L; Bergmann M; Kless S; Mack S; Jäger U; Patten N; Wu L; Wenger MK; Fingerle-Rowson G; Lichter P; Cazzola M; Wendtner CM; Fink AM; Fischer K; Busch R; Hallek M; Döhner H
Blood; 2014 May; 123(21):3247-54. PubMed ID: 24652989
[TBL] [Abstract][Full Text] [Related]
26. NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.
D'Agaro T; Bittolo T; Bravin V; Dal Bo M; Pozzo F; Bulian P; Rossi FM; Zucchetto A; Degan M; D'Arena G; Chiarenza A; Zaja F; Pozzato G; Di Raimondo F; Rossi D; Gaidano G; Del Poeta G; Gattei V; Bomben R
Br J Haematol; 2018 Aug; 182(4):597-602. PubMed ID: 28699643
[No Abstract] [Full Text] [Related]
27. Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism.
Secchiero P; Melloni E; di Iasio MG; Tiribelli M; Rimondi E; Corallini F; Gattei V; Zauli G
Blood; 2009 Apr; 113(18):4300-8. PubMed ID: 19190243
[TBL] [Abstract][Full Text] [Related]
28. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.
Díez P; Lorenzo S; Dégano RM; Ibarrola N; González-González M; Nieto W; Almeida J; González M; Orfao A; Fuentes M
Proteomics; 2016 Apr; 16(8):1193-203. PubMed ID: 26910488
[TBL] [Abstract][Full Text] [Related]
29. Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.
Zhang Q; Zhu Z; Guan J; Hu Y; Zhou W; Ye W; Lin B; Weng S; Chen Y; Zheng C
Mol Biotechnol; 2022 Dec; 64(12):1419-1430. PubMed ID: 35704163
[TBL] [Abstract][Full Text] [Related]
30. Constitutive activation of NF-κB signaling by NOTCH1 mutations in chronic lymphocytic leukemia.
Xu ZS; Zhang JS; Zhang JY; Wu SQ; Xiong DL; Chen HJ; Chen ZZ; Zhan R
Oncol Rep; 2015 Apr; 33(4):1609-14. PubMed ID: 25633905
[TBL] [Abstract][Full Text] [Related]
31.
Pozzo F; Bittolo T; Tissino E; Vit F; Vendramini E; Laurenti L; D'Arena G; Olivieri J; Pozzato G; Zaja F; Chiarenza A; Di Raimondo F; Zucchetto A; Bomben R; Rossi FM; Del Poeta G; Dal Bo M; Gattei V
Haematologica; 2021 Dec; 106(12):3125-3135. PubMed ID: 33121237
[TBL] [Abstract][Full Text] [Related]
32. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D
Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059
[TBL] [Abstract][Full Text] [Related]
33. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue.
Wołowiec D; Benchaib M; Pernas P; Deviller P; Souchier C; Rimokh R; Felman P; Bryon PA; Ffrench M
Leukemia; 1995 Aug; 9(8):1382-8. PubMed ID: 7643628
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
[TBL] [Abstract][Full Text] [Related]
35. THE SPECTRUM OF TP53, SF3B1, AND NOTCH1 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS EXPOSED TO IONIZING RADIATION DUE TO THE CHORNOBYL NPP ACCIDENT.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martina ZV; Saenko V; Bazyka DA
Probl Radiac Med Radiobiol; 2018 Dec; 23():283-301. PubMed ID: 30582853
[TBL] [Abstract][Full Text] [Related]
36. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
37. Clinical Value of NOTCH1 Mutations Detection among Chronic Lymphocytic Leukemia Patients.
Aref S; El-Agder M; Salama O; Abouzeid T; Sabry M
Asian Pac J Cancer Prev; 2020 May; 21(5):1295-1301. PubMed ID: 32458636
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of NOTCH1, MYD88, and SF3B1 mutations in Polish patients with chronic lymphocytic leukemia.
Putowski M; Podgórniak M; Piróg M; Knap J; Zaleska J; Purkot J; Zawiślak J; Zakrzewska E; Karczmarczyk A; Własiuk P; Subocz E; Giannopoulos K
Pol Arch Intern Med; 2017 Apr; 127(4):238-244. PubMed ID: 28424451
[TBL] [Abstract][Full Text] [Related]
39. Insulin growth factor 1 receptor expression is associated with NOTCH1 mutation, trisomy 12 and aggressive clinical course in chronic lymphocytic leukaemia.
Maura F; Mosca L; Fabris S; Cutrona G; Matis S; Lionetti M; Agnelli L; Barbieri M; D'Anca M; Manzoni M; Colombo M; Massucco C; Reverberi D; Gentile M; Recchia AG; Bossio S; Ilariucci F; Musolino C; Di Raimondo F; Cortelezzi A; Morabito F; Ferrarini M; Neri A
PLoS One; 2015; 10(3):e0118801. PubMed ID: 25786252
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.
Fabbri G; Rasi S; Rossi D; Trifonov V; Khiabanian H; Ma J; Grunn A; Fangazio M; Capello D; Monti S; Cresta S; Gargiulo E; Forconi F; Guarini A; Arcaini L; Paulli M; Laurenti L; Larocca LM; Marasca R; Gattei V; Oscier D; Bertoni F; Mullighan CG; Foá R; Pasqualucci L; Rabadan R; Dalla-Favera R; Gaidano G
J Exp Med; 2011 Jul; 208(7):1389-401. PubMed ID: 21670202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
